Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,170 public trials 550 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin

NCT00087568

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Bakersfield, California, United States

Pasadena, California, United States

San Diego, California, United States

San Mateo, California, United States

View all 25 locations

View Trial Details

Completed

Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects

NCT02456558

Conditions: Asymptomatic HIV Infection, Blood-Borne Infections, Communicable Diseases, +12 more
Locations: Phoenix Pharma Port Elizabeth, Eastern Cape, South Africa

VxPharma Pretoria, South Africa

View Trial Details

Completed

Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers

NCT02304185

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Miami, Florida, United States

View Trial Details

Completed

The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia

NCT02012816

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Center for Infectious Disease Research in Zambia Lusaka, Zambia

View Trial Details

Completed

Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection

NCT00959894

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

Carolinas Medical Center Charlotte, North Carolina, United States

Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected Patients

NCT02176525

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing

NCT01849653

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Chlamydia Infections, +15 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection

NCT01492426

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: The Kirklin Clinic Birmingham, Alabama, United States

Mayo Clinic Arizona Phoenix, Arizona, United States

Va Long Beach Healthcare System Long Beach, California, United States

Medical Associates Research Group San Diego, California, United States

View all 91 locations

View Trial Details

Completed

Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose

NCT01300988

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Clinical Trials Unit. University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults

NCT02099994

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations: KAVI-Kangemi clinic Nairobi, Kenya

View Trial Details

Communicable Diseases

Communicable Diseases trial results

Related conditions